Visit https://www.aetna.com/provweb/ to register to e-mail your requests for a faster response.
Medical Exception / Precertification* Request Form
For Prescription Medications
Please complete form and fax to: 1-800-408-2386 or call 1-800-414-2386.
Visit https://www.aetna.com/provweb/ to register to e-mail your requests for a faster response.
Visit www.aetna.com/formulary to access the Pharmacy Coverage Policy Bulletins.
Physician Signature (
REQUIRED)
Please circle
Antihistamine requested: ALLEGRA ALLEGRA-D CLARINEX SEMPREX-D ZYRTEC ZYRTEC-D
What is the patient’s diagnosis?
(circle all that apply) Allergic Rhinitis Chronic Idiopathic Urticaria Other _____________________
List previous therapy, including OTCs: _______________________________________Dates (
if available) __________________________
Response to previous therapy
(circle all that apply) Inadequate response Adverse effect(s) Comments ___________________________
Please circle
Proton Pump Inhibitor requested: ACIPHEX NEXIUM PREVACID PRILOSEC PROTONIX omeprazole (generic)
What dosage is being requested? _____mg
What is the patient’s diagnosis?
(circle all that apply) GERD Nocturnal acid breakthrough
Barrett esophagus Hypersecretory condition
List previous therapy, with dates: ______________________________________________________________________________________ Response to previous therapy
(circle all that apply) Inadequate response Adverse effect(s) Comments __________________________
Please circle
COX-II Selective Inhibitor requested:
What is the patient’s diagnosis?
(circle all that apply) Osteoarthritis
List previous therapy, with dates: _____________________________________________________________________________________ Response to previous therapy
(circle all that apply) Inadequate response Adverse effect(s) Comments ___________________________ Does the patient have a history of peptic ulcer disease or NSAID-related ulcer/GI bleeding?
Is the patient currently using anticoagulants, antiplatelets, or corticosteroids?
Please circle
Antifungal requested: DIFLUCAN
What is the patient’s diagnosis?
(circle all that apply) Onychomycosis Vulvovaginal Candidiasis Oral Candida (thrush)
Candida (esophageal, intestinal, UTI, other)
List previous therapy, with dates: _____________________________________________________________________________________
Response to previous therapy
(circle all that apply) Inadequate response Adverse effect(s) Comments ___________________________
FOR ONYCHOMYCOSIS: KOH, PAS, fungal culture results: _______ Test Date:__________ Location? Fingernail(s) Toenail(s)
What other conditions does patient have?
(circle all that apply) Pain Limiting Activity Diabetes Mellitus Immunosuppression (AIDS, cancer, etc.)
Systemic dermatosis
Peripheral vascular disease Other _______________
If prior onychomycosis therapy, please note: Drug: ________________ Start Date: ___________
Response to previous therapy
(circle all that apply) Inadequate response Adverse effect(s) Comments __________________________
Accutane, isotretinoin
What is the patient’s diagnosis? _______________________________________________________________________________________
P revious therapy:
(circle all that apply) doxycycline
Other _____________________________________
Response to previous therapy
(circle all that apply) Inadequate response Adverse effect(s) Comments ____________________________ If female, pregnancy test results: __________________
Test Date: ______________________________
For ALL other precertification/medical exception requests
Drug requested: ______________________________ Duration of therapy requested: ___________________________________
Diagnosis: __________________________________________________________________________________________________________
Previous therapy(ies) received, with duration: ____________________________________________________________________________
Previous therapy(ies) with inadequate therapeutic response ____________________________________________________________________
Previous therapy(ies) causing adverse effects _______________________________________________________________________________
Therapy(ies) contraindicated in patient ____________________________________________________________________________________
*The term precertification means the utilization review process to determine whether the requested service, procedure, prescription drug or medical device meets the company’s clinical criteria for coverage. IT does not mean precertification as defined by Texas law, as a reliable representation of payment of care or services to fully insured HMO and PPO member.
Source: http://www.resourcebenefitsinc.com/forms/AETNA/RXPreApprovalForm.pdf
DIÁRIO DA REPÚBLICA — I SÉRIE-A Por parte de Portugal, o Acordo foi aprovado pelositado o seu instrumento de adesão em 30 de SetembroDecreto n.o 10/90, publicado no Diário da República, de 2004, conforme o Aviso n.o 205/2004, publicado no1.a série, n.o 82, de 7 de Abril de 1990. Diário da República, 1.a série-A, n.o 297, de 21 de Dezem-Nos termos do artigo X do Acordo, este
Part XIV · Ginseng Establishment Insuring Agreement A. General “shade structures” means the posts and shade material used to control garden temperature and light intensity in This Part applies to ginseng seedlings, as defined in this “shade material” means either wooden lath or Except where otherwise provided, the insurance polypropylene cloth used to shade ginseng gardens.